R.S. IPRATROP 1.25 (Levosalbutamol & Ipratropium Bromide Respiratory Solution) is A prescription medication used to manage and prevent airway constriction associated with Chronic Obstructive Pulmonary Disease (COPD) and asthma. It helps relax airway muscles, improve airflow, and support better breathing when used as directed by a healthcare professional."

This combination therapy works through two different mechanisms to support airway opening and improve airflow. Levosalbutamol acts as a bronchodilator that helps relax airway muscles, while Ipratropium Bromide helps reduce airway narrowing through anticholinergic action.

R.S. IPRATROP 1.25 Respules are manufactured according to WHO-GMP certified quality standards and supplied in a convenient pack size of 50 respules for patients requiring prescribed nebulisation therapy.

Product Overview – Levosalbutamol & Ipratropium Bromide Respiratory Solution

Levosalbutamol & Ipratropium Bromide Respiratory Solution is designed for delivery through a nebuliser, which converts the liquid medicine into a fine mist that can be inhaled directly into the lungs.

This combination contains two bronchodilator medicines that work together to help relax airway muscles and support improved breathing in patients with conditions involving airway obstruction.

The medicine is commonly prescribed when a single bronchodilator may not provide sufficient airway relaxation. The combination approach helps target different pathways involved in breathing difficulty.

R.S. IPRATROP 1.25 should be used only according to the dosage and duration recommended by a registered medical practitioner.

Uses of Levosalbutamol & Ipratropium Bromide Respiratory Solution

Doctors may prescribe Levosalbutamol & Ipratropium Bromide Respiratory Solution for respiratory conditions where bronchodilator therapy is required.

Common uses may include:

• Management of airway obstruction-related breathing difficulties

• Supportive treatment in chronic respiratory conditions

• Relief of bronchospasm as prescribed by a doctor

• Nebulisation therapy for patients requiring combination bronchodilator treatment

This medicine should not be considered a replacement for emergency treatment during severe breathing episodes. Patients should follow their doctor’s complete respiratory care plan.

How Does Levosalbutamol & Ipratropium Bromide Respiratory Solution Work?

R.S. IPRATROP 1.25 contains two active ingredients with complementary actions:

Levosalbutamol Action

Levosalbutamol is a selective bronchodilator that works by relaxing the muscles around the airways. This helps widen the air passages and supports easier movement of air into and out of the lungs.

Ipratropium Bromide Action

Ipratropium Bromide is an anticholinergic bronchodilator. It helps reduce airway narrowing by blocking certain nerve signals that cause airway muscles to tighten.

Together, these ingredients help provide dual-action bronchodilation for patients who require prescribed inhalation therapy.

Benefits of Levosalbutamol & Ipratropium Bromide Respiratory Solution Respules

Key benefits of Levosalbutamol & Ipratropium Bromide Respiratory Solution include:

• Combination bronchodilator therapy

• Helps relax airway muscles

• Supports improved airflow in obstructive airway conditions

• Direct delivery of medicine through nebulisation

• Convenient single-dose respule format

• Manufactured under WHO-GMP certified standards

The effectiveness of treatment depends on individual health conditions, severity of symptoms, and proper use according to medical advice.

How to Use Levosalbutamol & Ipratropium Bromide Respules?

Use R.S. IPRATROP 1.25 only with a nebuliser device and follow your doctor’s instructions.

General steps:

1. Wash hands before using the respule.

2. Open the respule carefully.

3. Pour the prescribed solution into the nebuliser chamber.

4. Connect the mouthpiece or mask properly.

5. Breathe the mist as instructed until the medicine is finished.

6. Clean the nebuliser equipment after each use.

Do not swallow the respiratory solution. It is intended only for inhalation through a nebuliser.

Dosage Information

The dosage of Levosalbutamol & Ipratropium Bromide Respiratory Solution depends on:

• Patient age

• Severity of breathing symptoms

• Medical condition

• Response to treatment

• Other medicines being used

Your doctor will determine the correct dose and frequency. Do not increase or reduce the dose without professional medical advice.

Safety Information and Precautions

Before using R.S. IPRATROP 1.25, inform your doctor if you have:

• Heart-related conditions

• High blood pressure

• Diabetes

• Thyroid disorders

• Glaucoma

• Urinary problems

• Allergy to Levosalbutamol or Ipratropium

Possible side effects may include:

• Dry mouth

• Throat irritation

• Cough

• Headache

• Tremors

• Increased heart rate

Contact your healthcare provider if side effects continue or become severe.

Seek medical attention if you experience serious breathing problems, chest pain, or allergic reactions.

Storage Instructions

Store R.S. IPRATROP 1.25 Respules properly:

• Keep in a cool and dry place

• Protect from direct sunlight

• Keep away from excessive heat and moisture

• Store out of reach of children

• Check expiry date before use

Do not use damaged or expired respules.

Why Choose Levosalbutamol & Ipratropium Bromide Respiratory Solution  Respules?

R.S. IPRATROP 1.25 by Steris Healthcare Pvt Ltd provides a combination nebulisation solution for patients requiring prescribed bronchodilator therapy.

With WHO-GMP certified manufacturing standards and a 50-respule pack, it supports convenient and consistent respiratory care under medical supervision.

Since this is a prescription medicine, it should be purchased and used only according to a doctor’s recommendation.

Frequently Asked Questions 

1. What is Levosalbutamol & Ipratropium Bromide Respiratory Solution used for?

It is used to support breathing management in respiratory conditions where airway relaxation and bronchodilator therapy are required.

2. What is Levosalbutamol & Ipratropium Bromide Respiratory Solution?

R.S. IPRATROP 1.25 is a respiratory solution containing Levosalbutamol and Ipratropium Bromide, marketed by Steris Healthcare Pvt Ltd.

3. How does Levosalbutamol and Ipratropium Bromide work?

Levosalbutamol helps relax airway muscles, while Ipratropium Bromide helps reduce airway tightening through anticholinergic action.

4. Is Levosalbutamol & Ipratropium Bromide Respiratory Solution a steroid medicine?

No. R.S. IPRATROP 1.25 contains bronchodilator medicines and does not contain corticosteroids.

5. Can this medicine be used for sudden breathing attacks?

Use this medicine only as prescribed by your doctor. Emergency treatment decisions should always follow medical advice.

6. How should Levosalbutamol & Ipratropium Bromide Respiratory Solution Respules be used?

It should be used through a nebuliser device according to your doctor’s instructions.

7. Is Levosalbutamol & Ipratropium Bromide Respiratory Solution safe for children?

A healthcare professional should decide whether this medicine is suitable for children and determine the correct dose.

8. Does Levosalbutamol & Ipratropium Bromide Respiratory Solution require a prescription?

Yes. It is a prescription-only medicine and should be used with a valid prescription.

9. How many respules are available in one pack?

R.S. IPRATROP 1.25 is available in a pack containing 50 respules.

10. Who markets Levosalbutamol & Ipratropium Bromide Respiratory Solution Respules?

R.S. IPRATROP 1.25 Respules are marketed by Steris Healthcare Pvt Ltd.

Product Information 

Brand Name: R.S. IPRATROP 1.25
Composition: Levosalbutamol & Ipratropium Bromide Respiratory Solution
Formulation: Respiratory Solution (Respules)
Pack Size: 50 Respules
Marketed By: Steris Healthcare Pvt Ltd
Regulatory Standard: WHO-GMP Certified
Schedule: Prescription Only Medicine (Valid Prescription Required)